Royal Philips (NYSE:PHG) today said it has appointed Shez Partovi as chief innovation and strategy officer, effective July 1.
Partovi replaces Jeroen Tas and will report directly to CEO Frans van Houten. He will also join Philips’s executive committee on March 22 to ensure a seamless transition.
Tas will take on a part-time role at the company to focus on continuing the company’s strategic business development until the end of 2022.
Prior to joining the company, Partovi served as worldwide head of business development for healthcare, life sciences and medical devices and Amazon Web Services. He has also held numerous leadership roles at Dignity Health.
Philips also announced that strategic business development lead Rob Cascella will step down from the executive committee on April 1 to retire. He will remain as a special advisor on a part-time basis until the end of 2021.
“On behalf of Philips’ executive committee, I am very pleased to welcome Shez Partovi as our new Chief Innovation & Strategy Officer,” CEO Frans van Houten said in a news release. “Shez brings deep healthcare and informatics experience to Philips, which will be highly relevant as we accelerate the transition to becoming a solutions leader, leveraging deep clinical insights and big data analytics. I want to thank Jeroen and Rob for their very valuable contributions to the transformation of our company. Jeroen played a very important role in inspiring and executing our strategy for digital health and healthcare informatics, while Rob has contributed a wealth of experience and successfully shaped our diagnosis & treatment segment.”